SCHEMBL26242537

SCHEMBL26242537

Cc1nnc(-c2ccncc2)c(C)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.43
LMNA P02545 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.41
MAPK14 Q16539 4/20 0.39
MAPK11 Q15759 3/20 0.39
CSNK1D P48730 3/20 0.39
TP53 P04637 1/20 0.38
PKM P14618 1/20 0.38
MAPK13 O15264 1/20 0.38
MAPK12 P53778 1/20 0.38
SMO Q99835 1/20 0.38
NOTUM Q6P988 1/20 0.37
KIF11 P52732 1/20 0.35
PABPC1 P11940 1/20 0.35
APOBEC3A P31941 1/20 0.35
EIF4H Q15056 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
CSNK1A1 P48729 1/20 0.35
CLK2 P49760 1/20 0.35
CSNK1G1 Q9HCP0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26242505 0.82 MAOB (0.44) MAPTSMN1; SMN2MAPK14PKMCSNK1A1
SCHEMBL26242506 0.82 CNR1 (0.45) MAPTLMNASMN1; SMN2NOTUMKDM4E
SCHEMBL26242512 0.78 ADORA2A (0.44) MAPK14MAPK11CSNK1DMAPK13MAPK12
SCHEMBL15038342 0.78 LMNA (0.40) MAPTLMNASMN1; SMN2MAPK14MAPK11
SCHEMBL26242535 0.78 CYP2A6 (0.53) MAPTLMNASMN1; SMN2TP53HPGD
Ammonia Solution, Strong SCHEMBL17728179 0.78 SMN1; SMN2 (0.47) SMN1; SMN2MAPK14MAPK11CSNK1DMAPK13
SCHEMBL4092576 0.75 SMN1; SMN2 (0.49) MAPTLMNASMN1; SMN2MAPK14MAPK11
SCHEMBL26246652 0.75 KMT2A (0.54) MAPTLMNATP53HPGDGAA
SCHEMBL12668067 0.74 KDM4E (0.41) LMNAKDM4EALDH1A1ALOX15HSD17B10
SCHEMBL26242510 0.74 SMO (0.34) SMONOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023150201-A2 SODIUM CHANNEL BLOCKING COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE LATIGO BIOTHERAPEUTICS, INC. (US) 2023-08-10 WO disclosed
CN-1251097-B Phthalazines with angiogenesis inhibiting activity NOVARTIS AG 2011-10-19 CN disclosed
CN-1251097-A Phthalazines with angiogenesis inhibiting activity NOVARTIS AG (CH) 2000-04-19 CN disclosed